Increased choices of pneumococcal vaccines for policy makers

Lancet Infect Dis. 2023 May;23(5):519-520. doi: 10.1016/S1473-3099(22)00760-5. Epub 2023 Jan 10.

Authors

Hans-Christian Slotved¹, Kurt Fuursted²

Affiliations

¹ Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, DK-2300 Copenhagen S, Denmark. Electronic address: hcs@ssi.dk.
² Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, DK-2300 Copenhagen S, Denmark.

PMID: 36638818
DOI: 10.1016/S1473-3099(22)00760-5

No abstract available

Publication types

Comment

MeSH terms

Administrative Personnel
Health Policy
Humans
Pneumococcal Infections* / epidemiology
Pneumococcal Infections* / prevention & control
Pneumococcal Vaccines*
Vaccines, Conjugate

Substances

Pneumococcal Vaccines
Vaccines, Conjugate